While people of any racial or ethnic group can have alpha-1 antitrypsin deficiency (Alpha-1), its prevalence is significantly higher among those with European ancestry. In fact, approximately 1 in 25 people of European descent carry at least one abnormal copy of the gene associated with the condition. Despite its genetic frequency, Alpha-1 remains largely underdiagnosed for years. Many individuals experience symptoms without receiving a proper diagnosis, delaying access to care and increasing the risk of serious complications affecting both the lungs and the liver. Raising awareness is essential to ensure that patients living with AATD receive timely support and an accurate diagnosis. #Alpha1Awareness